Simulations Plus, Inc. — Chart, Price & News (NASDAQ:SLP)

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Market Capitalization 246.3122 M
Employee 213
Founded 1996
CEO N/A
Website www.simulations-plus.com
Headquarter North Carolina, United States
FIGI BBG000BS2ZD1
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

246.31 M Market capitalization

Price to earnings ratio

-4.47

Price to sales ratio

3.65

Dividends per share

—

Dividend yield %

—

Simulations Plus Inc

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

SLP

Financials

Simulations Plus Inc

뉴스

Sonos Q1 Earnings and Revenues Surpass Estimates, Stock Rises

Dolby's Q1 Earnings & Revenues Surpass Estimates, Fall Y/Y, Stock Down

Simulations Plus, Inc. (SLP) Analyst/Investor Day - Slideshow (NASDAQ:SLP) 2026-01-29

SAP's Q4 Earnings & Revenues Up Y/Y, Stock Down on Weak Cloud Backlog

Badger Meter's Q4 Earnings & Revenue Miss Estimates, Stock Down

Seagate's Q2 Earnings Top, Revenues Soar Y/Y on AI-Led Storage Demand

Iridium NTN Direct Sets for Beta Entry After Successful Testing

Simulations Plus, Inc. (SLP) Analyst/Investor Day Transcript

PTC Onshape Helps Reditus Space Accelerate Reusable Reentry Capsule

Is CDNS Worth Adding Despite Breakeven Returns in the Past Six Months?

SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales

Simulations Plus, Inc. (SLP) Q1 2026 Earnings Call Transcript